mono-pharmacare-ltd

Mono Pharmacare Ltd Financials
Company Logo

Mono Pharmacare Ltd Financial Statement

Mono Pharmacare Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

No Data Available

Mono Pharmacare Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual70.72
Operating Expenses Annual68.27
Operating Profit Annual4.15
Interest Annual1.21
Depreciation0.08
Net Profit Annual2.44
Tax Annual0.41

Mono Pharmacare Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning0.23
Cash Flow from Operations-10.32
Cash Flow from Investing-1.66
Cash Flow from Financing12
Cash Flow at the End0.25

Mono Pharmacare Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)5.97
PBIT Margin (%)5.85
PBT Margin (%)1.28
Net PROFIT Margin (%)3.45
Return On Networth / Equity (%)11.76
Return On Networth /Employed (%)12.27
Return On Assets (%)7.25
Total Debt / Equity (X)0.62
Asset Turnover Ratio (%)2.10

Mono Pharmacare Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual0.14
Total Current Assets Annual41.64
Non Current Assets Annual3.76
Total Shareholders Funds Annual28.11
Total Assets Annual45.40

Mono Pharmacare Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Dec 15, 2024, Mono Pharmacare Ltd has a market capitalization of 77.92 Cr. Value Research classifies it as a Micro-Cap company.
Yes, Mono Pharmacare Ltd is debt-free with a debt-to-equity ratio of 0.47.
In FY 2023 , Mono Pharmacare Ltd recorded a total revenue of approximately 70.72 Cr marking a significant milestone in the company's financial performance.
Mono Pharmacare Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately Infinity% and 0.4% annually, respectively..
Mono Pharmacare Ltd's current PE ratio is 31.93.
Mono Pharmacare Ltd's ROCE averaged 9.7% from the FY ending March 2023 to 2024, with a median of 9.7%. It peaked at 9.8% in March 2024, reflecting strong capital efficiency over the period..
Mono Pharmacare Ltd's latest EBIT is Rs. 4.07 Cr, surpassing the average EBIT of Rs. 3.29 Cr over the 5 years..
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions